InsidersTradesSigma
Explore the complete record of transactions filed by Faga Daniel, Chief Executive Officer. Officer active across 1 company, notably Anaptysbio, INC. Cumulatively, 1 reports have been published. Activity tracked since 21 March 2022. The latest transaction was disclosed on 21 March 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Faga Daniel serves as the Interim CEO of ANAPTYSBIO, INC. In this role, he oversees the company's operations and leads strategic initiatives during the transition period. Daniel leverages his management expertise to guide ANAPTYSBIO, a biopharmaceutical company, in its product development efforts. His role is essential in ensuring operational continuity and achieving the company's objectives.